Patents by Inventor Alan C. Foster

Alan C. Foster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131189
    Abstract: Described herein are variant adeno-associated virus (AAV) capsid polypeptides and gene therapeutics thereof for use in the treatment or prevention of hearing loss.
    Type: Application
    Filed: May 4, 2023
    Publication date: April 25, 2024
    Inventors: Steven Pennock, Adrian M. Timmers, Mark Shearman, Christopher Bartolome, Wang Xiaobo, Prahav Dinesh Mathur, Phillip M. Uribe, Stephanie Szobota, Bonnie E. Jacques, Alan C. Foster, Fabrice Piu
  • Publication number: 20170172959
    Abstract: The present invention relates to therapeutic methods using pharmaceutical compositions comprising one or a combination of co-agonists at the N-methyl-D-aspartate receptor for the treatment of visual system disorders.
    Type: Application
    Filed: July 26, 2016
    Publication date: June 22, 2017
    Inventors: Yong-Xin Li, Alan C. Foster, Ursula V. Staubli, John E. Donello, Miguel Alcantara
  • Publication number: 20170172957
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: July 29, 2016
    Publication date: June 22, 2017
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • Patent number: 9415031
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: August 16, 2016
    Assignee: Allergan, Inc.
    Inventors: Veena Viswanath, Alan C. Foster, Yong-Xin Li, Ursula V. Staubli, Lauren M. Luhrs
  • Publication number: 20150174095
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors which are proline analogues and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
    Type: Application
    Filed: December 23, 2014
    Publication date: June 25, 2015
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula V. Staubli
  • Publication number: 20140221453
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
    Type: Application
    Filed: April 8, 2014
    Publication date: August 7, 2014
    Applicant: Allergan, Inc.
    Inventors: Veena Viswanath, Alan C. Foster, Yong-Xin Li, Ursula V. Staubli, Lauren M. Luhrs
  • Publication number: 20140200254
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: March 17, 2014
    Publication date: July 17, 2014
    Applicant: Allergan, Inc.
    Inventors: ALAN C. FOSTER, YONG-XIN Li, URSULA STAUBLI, VEENA VISWANATH, LAUREN LUHRS
  • Patent number: 8741955
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: June 3, 2014
    Assignee: Allergan, Inc.
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • Patent number: 8735451
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: May 27, 2014
    Assignee: Allergan, Inc.
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula V. Staubli, Veena Viswanath, Lauren M. Luhrs
  • Publication number: 20130023573
    Abstract: The present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptors.
    Type: Application
    Filed: July 18, 2012
    Publication date: January 24, 2013
    Inventors: Ursula V. Staubli, Alan C. Foster, Daniel W. Gil, John E. Donello
  • Publication number: 20120329873
    Abstract: The present invention relates to therapeutic methods using pharmaceutical compositions comprising one or a combination of co-agonists at the N-methyl-D-aspartate receptor for the treatment of visual system disorders.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 27, 2012
    Inventors: YONG-XIN Li, Alan C. Foster, Ursula V. Staubli, John E. Donello, Miguel Alcantara
  • Publication number: 20120329851
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: May 24, 2012
    Publication date: December 27, 2012
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • Publication number: 20120302621
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula V. Staubli, Veena Viswanath, Lauren M. Luhrs
  • Publication number: 20110257186
    Abstract: Disclosed are methods of treating disorders of the eye by administering to a patient in need of such treatment a compound represented by the formula Wherein R1 and R2 are independently hydrogen, alkyl, substituted alkyl, cycloalkyl, alkynyl, substituted alkynyl, cyano, alkoxy, carboxamido, substituted carboxamido, and if R1 and R2 are alkyl, R1 and R2 may be joined with a bond or —(CH2)m— to produce a cycloalkyl, R3 and R4 are independently hydrogen, alkyl, hydroxyl, alkoxy, cyano, fluoro, and if R3 and R4 are alkyl, R3 and R4 may be joined with a bond or —(CH2)m— to produce a cycloalkyl, Q may be absent, hydrogen, alkyl, cycloalkyl, cycloalkenyl, alkoxy, substituted alkoxy, substituted thio, cyano, thionitrile, sulfonamide, substituted sulfonamide, substituted sulfonyl, aromatic, substituted aromatic, heteroaromatic, substituted heteroaromatic, or bicycloheteroaromatic, R5 is hydrogen, alkyl, cycloalkyl, or when R6 is also alkyl, together with R6 may form a heterocycloalkyl ring, R6 may be hydrogen, alky
    Type: Application
    Filed: April 12, 2011
    Publication date: October 20, 2011
    Inventors: Ursula V. Staubli, Yong-Xin Li, Alan C. Foster